Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 10
475
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Cytotoxic alkaloids from the root of Zanthoxylum paracanthum (mildbr) Kokwaro

ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , & show all
Pages 2518-2525 | Received 10 Dec 2020, Accepted 31 Mar 2021, Published online: 08 May 2021
 

Abstract

Chemical investigation of the root of Zanthoxylum paracanthum afforded 1 new alkamide derivative, (2E,4E)-6-oxo-N-isobutyldeca-2,4-dienamide (1) together with 10 known congeners including one phenolic amide (2), four benzophenanthridines (3 − 6), three indolonaphthyridines (7 − 9) and two lignans (10 and 11). Their structures were elucidated by a combination of spectroscopic and spectrometric data. Using resazurin reduction assay, the crude extract (10 µg/mL) and isolates (10 µM) were screened for their cytotoxic activities against the drug-sensitive (CCRF-CEM) leukemia cell line and its multidrug-resistant counterpart (CEM/ADR5000). Compounds 3, 4 and 6 showed cytotoxicity against CCRF-CEM with IC50 values of 2.00 ± 0.33, 2.31 ± 0.20 and 0.11 ± 0.04 µM, respectively. Only compound 6 exhibited strong cytotoxic activity against CEM/ADR5000 with an IC50 value of 2.34 ± 0.34 µM in comparison with the standard drug doxorubicin which showed IC50 values of 0.01 ± 0.14 (CCRF-CEM) and 26.78 ± 3.30 µM (CEM/ADR5000).

Graphical Abstract

Acknowledgements

Special thanks to Mr. Patrick Mutiso of the Herbarium, School of Biological Science, University of Nairobi for authentication of the plant material. We are also thankful to Dr. Wolf Hiller (Faculty of Chemistry and Chemical Biology, TU Dortmund) for NMR analysis, Drs. K.G. Bedane and G.T.M. Bitchagno for valuable discussions. Special thank go to Mrs. Eva Maria Wieczorek (INFU, TU Dortmund) for acquisitions of HRESIMS.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

L. K. Omosa is grateful for the financial support from the International Science Program (ISP) Sweden, through the KEN-02 project.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.